carnitine has been researched along with Cystic Fibrosis of Pancreas in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma carnitine concentrations were measured in 43 children and adults with cystic fibrosis (CF), and values were compared with those from normal controls." | 7.69 | Plasma carnitine levels in cystic fibrosis. ( Kovesi, TA; Lehotay, DC; Levison, H, 1994) |
| "Carnitine deficiency in the serum was found in 5 infants with cystic fibrosis, impaired liver function and neurological symptoms." | 7.69 | [Total carnitine level in infants with cystic fibrosis and deficit supplementation by means of pharmacologic preparations and diet. Introductory remarks]. ( Bujniewicz, E; Chlebowczyk, U; Krauze, M; Maliszewska, I; Mastalerz, Z; Szymańska, M; Woś, H, 1995) |
| "Acylcarnitine is low in cord blood in patients with cystic fibrosis, suggesting that fatty acid metabolism is disturbed in utero." | 7.68 | Carnitine metabolites in infants with cystic fibrosis: a prospective study. ( Lloyd-Still, JD; Powers, CA; Wessel, HU, 1993) |
| "Carnitine metabolites (total, free, short and long chain) were analyzed in cord blood of cystic fibrosis (n = 5), non-CF siblings (n = 7), and controls (n = 8)." | 7.68 | Acylcarnitine is low in cord blood in cystic fibrosis. ( Bohan, T; Hughes, S; Lloyd-Still, JD; Wessel, HU, 1990) |
| "Massive hepatomegaly and steatosis developed in the baby at a time of severe viral respiratory illness, prolonged fasting, hypoglycemia, and hypoketonuria." | 5.28 | Massive hepatomegaly, steatosis, and secondary plasma carnitine deficiency in an infant with cystic fibrosis. ( Stanley, CA; Treem, WR, 1989) |
| "Plasma carnitine concentrations were measured in 43 children and adults with cystic fibrosis (CF), and values were compared with those from normal controls." | 3.69 | Plasma carnitine levels in cystic fibrosis. ( Kovesi, TA; Lehotay, DC; Levison, H, 1994) |
| "Carnitine deficiency in the serum was found in 5 infants with cystic fibrosis, impaired liver function and neurological symptoms." | 3.69 | [Total carnitine level in infants with cystic fibrosis and deficit supplementation by means of pharmacologic preparations and diet. Introductory remarks]. ( Bujniewicz, E; Chlebowczyk, U; Krauze, M; Maliszewska, I; Mastalerz, Z; Szymańska, M; Woś, H, 1995) |
| "Acylcarnitine is low in cord blood in patients with cystic fibrosis, suggesting that fatty acid metabolism is disturbed in utero." | 3.68 | Carnitine metabolites in infants with cystic fibrosis: a prospective study. ( Lloyd-Still, JD; Powers, CA; Wessel, HU, 1993) |
| "Carnitine metabolites (total, free, short and long chain) were analyzed in cord blood of cystic fibrosis (n = 5), non-CF siblings (n = 7), and controls (n = 8)." | 3.68 | Acylcarnitine is low in cord blood in cystic fibrosis. ( Bohan, T; Hughes, S; Lloyd-Still, JD; Wessel, HU, 1990) |
| "Massive hepatomegaly and steatosis developed in the baby at a time of severe viral respiratory illness, prolonged fasting, hypoglycemia, and hypoketonuria." | 1.28 | Massive hepatomegaly, steatosis, and secondary plasma carnitine deficiency in an infant with cystic fibrosis. ( Stanley, CA; Treem, WR, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joseloff, E | 1 |
| Sha, W | 1 |
| Bell, SC | 1 |
| Wetmore, DR | 1 |
| Lawton, KA | 1 |
| Milburn, MV | 1 |
| Ryals, JA | 1 |
| Guo, L | 1 |
| Muhlebach, MS | 1 |
| Kovesi, TA | 1 |
| Lehotay, DC | 1 |
| Levison, H | 1 |
| Lloyd-Still, JD | 3 |
| Powers, CA | 1 |
| Wessel, HU | 2 |
| Woś, H | 1 |
| Krauze, M | 1 |
| Bujniewicz, E | 1 |
| Chlebowczyk, U | 1 |
| Mastalerz, Z | 1 |
| Szymańska, M | 1 |
| Maliszewska, I | 1 |
| Powers, C | 1 |
| Bohan, T | 1 |
| Hughes, S | 1 |
| Treem, WR | 1 |
| Stanley, CA | 1 |
7 other studies available for carnitine and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.
Topics: Adolescent; Amino Acids; Bile Acids and Salts; Biomarkers; Carnitine; Case-Control Studies; Child; C | 2014 |
Plasma carnitine levels in cystic fibrosis.
Topics: Adolescent; Adult; Carnitine; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Male | 1994 |
Carnitine metabolites in infants with cystic fibrosis: a prospective study.
Topics: Acetylcarnitine; Age Factors; Carnitine; Child, Preschool; Cystic Fibrosis; Energy Metabolism; Human | 1993 |
[Total carnitine level in infants with cystic fibrosis and deficit supplementation by means of pharmacologic preparations and diet. Introductory remarks].
Topics: Cardiomegaly; Carnitine; Cystic Fibrosis; Enteral Nutrition; Food, Fortified; Hepatomegaly; Humans; | 1995 |
Carnitine metabolites in infants with cystic fibrosis.
Topics: Age Factors; Carnitine; Cystic Fibrosis; Dietary Proteins; Humans; Infant | 1990 |
Acylcarnitine is low in cord blood in cystic fibrosis.
Topics: Acylation; Carnitine; Cystic Fibrosis; Fatty Acids, Essential; Female; Fetal Blood; Humans; Infant, | 1990 |
Massive hepatomegaly, steatosis, and secondary plasma carnitine deficiency in an infant with cystic fibrosis.
Topics: Carnitine; Combined Modality Therapy; Cystic Fibrosis; Fatty Liver; Glycine max; Hepatomegaly; Human | 1989 |